Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

New Zealand (NZX) Healthcare Sector Analysis

UpdatedJul 10, 2026
DataAggregated Company Financials
Companies14
  • 7D3.2%
  • 3M3.6%
  • 1Y-5.6%
  • YTD-3.4%

The Healthcare industry is up 2.5% in the last week, with Fisher & Paykel Healthcare up 3.1%. In the past year, the industry is down 7.1%. Looking forward, earnings are forecast to grow by 21% annually.

Sector Valuation and Performance

Has the New Zealand Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 10 Jul 2026NZ$34.1bNZ$20.1bNZ$828.2m16.5x41.2x1.7x
Sun, 07 Jun 2026NZ$31.8bNZ$20.2bNZ$829.6m16.8x38.3x1.6x
Tue, 05 May 2026NZ$31.6bNZ$20.0bNZ$453.0m18.4x69.7x1.6x
Thu, 02 Apr 2026NZ$32.0bNZ$19.8bNZ$449.3m17.4x71.2x1.6x
Sat, 28 Feb 2026NZ$35.5bNZ$19.6bNZ$552.6m18x64.3x1.8x
Mon, 26 Jan 2026NZ$35.4bNZ$18.3bNZ$534.5m19.9x66.3x1.9x
Wed, 24 Dec 2025NZ$35.4bNZ$18.1bNZ$531.7m21.2x66.6x2x
Fri, 21 Nov 2025NZ$34.8bNZ$18.1bNZ$583.8m20.4x59.7x1.9x
Sun, 19 Oct 2025NZ$33.6bNZ$17.8bNZ$574.0m19.8x58.5x1.9x
Tue, 16 Sep 2025NZ$34.3bNZ$17.6bNZ$570.8m17.9x60.1x2x
Thu, 14 Aug 2025NZ$36.0bNZ$17.6bNZ$571.7m18.7x62.9x2x
Sat, 12 Jul 2025NZ$35.8bNZ$17.6bNZ$570.5m17.9x62.8x2x
Mon, 09 Jun 2025NZ$35.0bNZ$17.4bNZ$568.0m14.8x61.6x2x
Wed, 07 May 2025NZ$34.4bNZ$17.3bNZ$654.4m14.9x52.6x2x
Fri, 04 Apr 2025NZ$34.6bNZ$17.4bNZ$657.0m16.9x52.6x2x
Sun, 02 Mar 2025NZ$33.7bNZ$17.6bNZ$661.6m16.6x51x1.9x
Tue, 28 Jan 2025NZ$36.8bNZ$18.2bNZ$734.4m14.5x50.2x2x
Thu, 26 Dec 2024NZ$36.9bNZ$18.2bNZ$727.9m12.4x50.7x2x
Sat, 23 Nov 2024NZ$36.6bNZ$18.1bNZ$827.4m24.1x44.2x2x
Mon, 21 Oct 2024NZ$37.4bNZ$18.3bNZ$967.8m20.1x38.7x2.1x
Wed, 18 Sep 2024NZ$37.6bNZ$18.1bNZ$963.7m20x39x2.1x
Fri, 16 Aug 2024NZ$35.1bNZ$17.6bNZ$975.6m20x36x2x
Sun, 14 Jul 2024NZ$31.5bNZ$17.7bNZ$977.2m16.8x32.2x1.8x
Tue, 11 Jun 2024NZ$30.0bNZ$17.3bNZ$960.7m17.3x31.3x1.7x
Thu, 09 May 2024NZ$30.7bNZ$17.4bNZ$1.3b24.1x23.8x1.8x
Sat, 06 Apr 2024NZ$29.4bNZ$17.4bNZ$1.3b23.8x22.9x1.7x
Mon, 04 Mar 2024NZ$28.9bNZ$17.0bNZ$1.3b18.5x22.4x1.7x
Wed, 31 Jan 2024NZ$29.4bNZ$16.7bNZ$1.1b20.6x26x1.8x
Fri, 29 Dec 2023NZ$28.7bNZ$16.7bNZ$1.1b23.4x25.4x1.7x
Sun, 26 Nov 2023NZ$27.5bNZ$16.5bNZ$1.1b23.1x24.4x1.7x
Tue, 24 Oct 2023NZ$26.8bNZ$16.5bNZ$1.1b31x24.2x1.6x
Thu, 21 Sep 2023NZ$28.3bNZ$16.5bNZ$1.1b29.6x25.6x1.7x
Sat, 19 Aug 2023NZ$28.7bNZ$15.8bNZ$1.1b28.9x26.7x1.8x
Mon, 17 Jul 2023NZ$30.9bNZ$15.7bNZ$1.1b30.1x28.8x2x
Price to Earnings Ratio

28.8x


Total Market Cap: NZ$30.9bTotal Earnings: NZ$1.1bTotal Revenue: NZ$15.7bTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Healthcare Sector Price to Earnings3Y Average 44.8x202420252026
Current Industry PE
  • Investors are pessimistic on the New Zealander Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 40.7x which is lower than its 3-year average PE of 44.8x.
  • The industry is trading close to its 3-year average PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 8.2% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare sector?

NZ Market0.93%
Healthcare3.17%
Pharma6.37%
Healthcare Services3.52%
Medical Equipment3.10%
Biotech-5.00%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 81.5x.
    • Analysts are expecting annual earnings growth of 13.3%, which is lower than the prior year's growth of 24.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 65% over the next 5 years.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FPH Fisher & Paykel HealthcareNZ$40.253.1%
+NZ$710.6m		11.2%PE50.5x
EBO EBOS GroupNZ$22.158.0%
+NZ$341.5m		-45.1%PE16.5x
AFT AFT PharmaceuticalsNZ$3.916.5%
+NZ$25.2m		47.0%PE27.8x
BLT BLIS TechnologiesNZ$0.0176.3%
+NZ$1.3m		-5.6%PE31.4x
PHL Promisia HealthcareNZ$0.601.7%
+NZ$528.0k		48.1%PE2.5x

Latest News

MEE
NZ$0.044
Me Today
7D
-10.2%
1Y
-40.5%
EBO
NZ$22.15
EBOS Group
7D
8.0%
1Y
-45.1%
Narrative Update • Jul 08

EBO: Distribution Contracts And Animal Care Expansion Will Support Future Upside Potential

Analysts have adjusted their price target on EBOS Group to reflect a revised fair value of NZ$36.57, down from NZ$41.16. They cite updated assumptions for discount rates, revenue growth, profit margins, and future P/E multiples.
FPH
NZ$40.25
Fisher & Paykel Healthcare
7D
3.1%
1Y
11.2%
Narrative Update • Jul 08

FPH: Removal From Conviction List Will Meet Higher Dividend Outlook

Analysts have modestly raised the fair value estimate for Fisher & Paykel Healthcare from NZ$46.00 to NZ$47.00, citing updated assumptions on revenue growth, profit margins, and future P/E multiples, along with the stock's recent removal from an APAC Conviction List. What's in the News for Fisher & Paykel Healthcare Fisher & Paykel Healthcare Corporation Limited announced a dividend of NZ$0.38823529 per share for the six months ended March 31, 2026.
BLT
NZ$0.017
BLIS Technologies
7D
6.3%
1Y
-5.6%
PEB
NZ$0.28
Pacific Edge
7D
-5.0%
1Y
176.7%
OCA
NZ$0.74
Oceania Healthcare
7D
-0.7%
1Y
-0.7%
Narrative Update • Jun 26

OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings

Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.
RYM
NZ$2.16
Ryman Healthcare
7D
-0.5%
1Y
-9.6%
Narrative Update • Jun 14

RYM: Capital Management And Governance Turnaround Will Support Future Upside

Analysts have kept their NZ$ fair value estimate for Ryman Healthcare unchanged, pointing to only very small adjustments in the discount rate, revenue growth outlook, profit margin assumptions and future P/E that did not materially shift their overall price target narrative. What's in the News Ryman Healthcare completed a six year fixed rate secured unsubordinated bond offer, allocating NZ$150 million after taking up oversubscriptions beyond the initial NZ$100 million target.
AFT
NZ$3.91
AFT Pharmaceuticals
7D
6.5%
1Y
47.0%
PHL
NZ$0.60
Promisia Healthcare
7D
1.7%
1Y
48.1%
Analysis Article • Jun 04

We Think That There Are Issues Underlying Promisia Healthcare's (NZSE:PHL) Earnings

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...